Monographie - Insulin lyspro

Viimeisin päivitys :
08/05/2024

Insulin lyspro

Kauppanimi

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Humalog

Argentiina, Belgia, Chile, Ecuador, Espanja, Etelä-Afrikka, Hollanti, Irlanti, Islanti, Iso-Britannia, Italia, Itävalta, Japani, Kanada, Kolumbia, Kreikka, Kroatia, Luxemburg, Malesia, Marokko, Meksiko, Norja, Portugali, Puola, Ranska, Romania, Ruotsi, Saksa, Saudi-Arabia, Slovenia, Suomi, Sveitsi, Tanska, Turkki, Unkari, Venezuela, Yhdysvallat

Viitteet : Insulin lyspro

	Tyyppi	Julkaisu
2269	Lehti	Chan P, Bishop A, Kupiec TC, Trissel LA, Gole D, Jimidar IM, Vermeersch H. Compatibility of ceftobiprole medocaril with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2008 ; 65, 16: 1545-1551.
3149	Lehti	DeFelippis MR, Bell MA, Heyob JA, Storms SM. In Vitro Stability of Insulin Lispro in Continuous Subcutaneous Insulin Infusion. Diabetes Tech and Ther 2006 ; 8, 3: 358-368.
3249	Lehti	Singh BM, Dedhiya MG, Dinunzio J, Chan P, Kupiec TC, Trissel LA, Laudano JB. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2011 ; 68: 2163-2169.
4433	Lehti	Ghazi I.M, El Nekidy W.S, Sood A, Dulku A, Patel R, Patel K. Y-site Administration of Imipenem/Cilastatin/ Relebactam With Common Intravenous Medications Clin Ther 2020 ; 42, 3: 475-485.
4650	Laboratorio	Ceftobiprole (Zevtera 500 mg powder for concentrate for solution for infusion.) Summary of Product Characteristics, Advanz Pharma updated 4 aug 2021. Advanz Pharma 2021

Mentions Légales